Free press releases distribution network?

Agency / Source: Akers Biosciences, Inc. (ABI)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Akers Biosciences, Inc. Announced 2007 Annual Financial Results - ABI, manufacturer of rapid diagnostic products, announced that 2007 revenues totaled $5.5M, the highest in company history - AkersBiosciences.com
Akers Biosciences, Inc. Announced 2007 Annual Financial Results

 

PRZOOM - /newswire/ - Thorofare, NJ, United States, 2008/04/07 - ABI, manufacturer of rapid diagnostic products, announced that 2007 revenues totaled $5.5M, the highest in company history - AkersBiosciences.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Other highlights include the first positive EBITDA of $1.4M which represents ABI’s maiden positive operating cash flow.

Akers Biosciences, Inc. a leading designer and manufacturer of rapid diagnostic screening and testing products, announces its annual results for the year ended 31 December, 2007.

2007 Highlights:
· Revenues of $5.5 million (2006: $ 1.0 million) are the highest in the Company’s history
· First positive EBITDA of $1.4 million (2006: negative EBITDA of $7.8 million)
· Maiden positive cash flow from operations
· Significant orders from United States military departments received and shipped
· $4.5 million in fixed convertible debt financing completed during the period to enhance stability of capital structure
· Acquisition completed of ‘Bout Time Marketing, LLC, a distributor of breathalyzer product, providing a direct channel to the US Military for BreathScan ® resulting in increased margins.
· New distribution arrangement signed for Tier 1 status with Cardinal Health, a distributor to over 4,000 US hospitals, resulted in a significant increase in sales of the PIFA Heparin/Platelet Factor 4 Rapid Assay.

Thomas A. Nicolette, Chief Executive Officer of ABI, commented: “In early 2007 we set about to effect a bold and immediate transition. Our strategy has been to transform the significant investment in our patented platform technologies over the past decade into real value by establishing routes to markets of our core products leading to profitable revenue generation. In 2007 we achieved that with the highest sales in the Company’s history, its first positive EBITDA from operations and the establishment of significant recurring revenue streams. These are the foundation blocks upon which we intend to build our core product line sales both domestically and abroad and bring forward new and mass market potential products."

About Akers Biosciences, Inc. (ABI)

Akers Biosciences, Inc. (akersbiosciences.com) was founded in 1989, with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians can obtain single-patient results. The tests and sample preparation devices that emerge from our rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Akers Biosciences, Inc. (ABI)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Akers Biosciences, Inc. Announced 2007 Annual Financial Results

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Patrice McMorrow - AkersBiosciences.com 
856-848-2116 pmcmorrow[.]akersbiosciences.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Akers Biosciences, Inc. (ABI) securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Akers Biosciences, Inc. (ABI) / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today